Kevin M Wheelock1, Mamta Jaiswal2, Catherine L Martin2, Gudeta D Fufaa1, E Jennifer Weil1, Kevin V Lemley3, Berne Yee4, Eva Feldman5, Frank C Brosius2, William C Knowler1, Robert G Nelson6, Rodica Pop-Busui2. 1. Phoenix Epidemiology and Clinical Research Branch, Phoenix, AZ. 2. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI. 3. Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA. 4. Southwest Kidney Institute, Phoenix, AZ. 5. Department of Neurology, University of Michigan Medical School, Ann Arbor, MI. 6. Phoenix Epidemiology and Clinical Research Branch, Phoenix, AZ. Electronic address: rnelson@phx.niddk.nih.gov.
Abstract
AIMS: Cardiovascular autonomic neuropathy (CAN) predicts clinical diabetic nephropathy (DN). We investigated the relationship between DN structural lesions and CAN. METHODS: Sixty three Pima Indians with type 2 diabetes underwent kidney biopsies following a 6-year clinical trial testing the renoprotective efficacy of losartan vs. placebo. CAN was assessed a median 9.2years later. CAN variables included expiration/inspiration ratio (E/I), standard deviation of the normal R-R interval (sdNN), and low and high frequency signal power and their ratio (LF, HF, LF/HF); lower values reflect more severe neuropathy. Associations of CAN with renal structural variables were assessed by linear regression adjusted for age, sex, diabetes duration, blood pressure, HbA1c, glomerular filtration rate, and treatment assignment during the trial. RESULTS: Global glomerular sclerosis was negatively associated with sdNN (partial r=-0.35, p=0.01) and LF (r=-0.32, p=0.02); glomerular basement membrane width was negatively associated with all measures of CAN except for LF/HF (r=-0.28 to -0.42, p<0.05); filtration surface density was positively associated with sdNN, LF, and HF (r=0.31 to 0.38, p<0.05); and cortical interstitial fractional volume was negatively associated with HF (r=-0.27, p=0.04). CONCLUSIONS: CAN associates with DN lesions. Published by Elsevier Inc.
AIMS: Cardiovascular autonomic neuropathy (CAN) predicts clinical diabetic nephropathy (DN). We investigated the relationship between DN structural lesions and CAN. METHODS: Sixty three Pima Indians with type 2 diabetes underwent kidney biopsies following a 6-year clinical trial testing the renoprotective efficacy of losartan vs. placebo. CAN was assessed a median 9.2years later. CAN variables included expiration/inspiration ratio (E/I), standard deviation of the normal R-R interval (sdNN), and low and high frequency signal power and their ratio (LF, HF, LF/HF); lower values reflect more severe neuropathy. Associations of CAN with renal structural variables were assessed by linear regression adjusted for age, sex, diabetes duration, blood pressure, HbA1c, glomerular filtration rate, and treatment assignment during the trial. RESULTS: Global glomerular sclerosis was negatively associated with sdNN (partial r=-0.35, p=0.01) and LF (r=-0.32, p=0.02); glomerular basement membrane width was negatively associated with all measures of CAN except for LF/HF (r=-0.28 to -0.42, p<0.05); filtration surface density was positively associated with sdNN, LF, and HF (r=0.31 to 0.38, p<0.05); and cortical interstitial fractional volume was negatively associated with HF (r=-0.27, p=0.04). CONCLUSIONS:CAN associates with DN lesions. Published by Elsevier Inc.
Entities:
Keywords:
American Indians; Cardiovascular autonomic neuropathy; Diabetic nephropathy; Kidney biopsy; Type 2 diabetes
Authors: Meda E Pavkov; Clinton C Mason; Peter H Bennett; Jeffrey M Curtis; William C Knowler; Robert G Nelson Journal: Diabetes Care Date: 2009-07-10 Impact factor: 17.152
Authors: E Jennifer Weil; Gudeta Fufaa; Lois I Jones; Tracy Lovato; Kevin V Lemley; Robert L Hanson; William C Knowler; Peter H Bennett; Berne Yee; Bryan D Myers; Robert G Nelson Journal: Diabetes Date: 2013-04-01 Impact factor: 9.461
Authors: Mamta Jaiswal; Jasmin Divers; Elaine M Urbina; Dana Dabelea; Ronny A Bell; David J Pettitt; Giuseppina Imperatore; Catherine Pihoker; Lawrence M Dolan; Angela D Liese; Santica Marcovina; Barbara Linder; Eva L Feldman; Rodica Pop-Busui Journal: Pediatr Diabetes Date: 2018-01-02 Impact factor: 4.866
Authors: Christian S Hansen; Tommi Suvitaival; Simone Theilade; Ismo Mattila; Maria Lajer; Kajetan Trošt; Linda Ahonen; Tine W Hansen; Cristina Legido-Quigley; Peter Rossing; Tarunveer S Ahluwalia Journal: Front Endocrinol (Lausanne) Date: 2022-04-14 Impact factor: 6.055
Authors: Rodica Pop-Busui; Andrew J M Boulton; Eva L Feldman; Vera Bril; Roy Freeman; Rayaz A Malik; Jay M Sosenko; Dan Ziegler Journal: Diabetes Care Date: 2017-01 Impact factor: 19.112